| abstract |
FIELD: pharmaceutics. n SUBSTANCE: invention relates to novel conjugates of glucagon superfamily peptides, which are conjugated with the ligand that is capable of acting at a nuclear hormone receptor of type I. n EFFECT: present invention also refers to pharmaceutical compositions containing said conjugates, and methods of treating a disease, for example, a metabolic disorder, diabetes or obesity. n 15 cl, 19 dwg, 15 tbl, 31 ex |